相关实验视频

Updated: May 23, 2025

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

结肠直肠癌:Her2/neu表达,Ki-67评分,瘤芽和临床病理参数之间是否存在任何相关性? - - 一项基于机构的前性研究

Susnata Khan¹, Senjuti Dasgupta², Asit Ranjan Deb³

¹Department of Pathology, Midnapore Medical College and Hospital, Midnapore, West Bengal, India.

South Asian journal of cancer

|March 10, 2025

概括

瘤芽是结直肠癌的一个明确的预后因素. 需要进一步的研究来证实Her2/neu表达和Ki67得分在更大的患者群体中的预后价值.

科学领域:

在瘤学瘤学.
病理学病理学病理学
癌症研究癌症研究

背景情况:

结肠直肠癌 (CRC) 是全球癌症死亡的主要原因.
在CRC中,Her2/neu表达,Ki67得分和瘤芽是公认的独立预后因素.
了解这些标志物有助于预测患者的结果,并指导治疗策略.

研究的目的:

为了评估Her2 / neu表达,Ki67得分和瘤芽指数在结直肠癌的侵袭边缘.
研究这些标记物与各种临床病理因素之间的相关性.
评估它们作为CRC中的预后指标的潜力.

主要方法:

一项为期18个月的观测横截面研究包括41名经组织学确认的CRC.患者.
针对Her2/neu和Ki-67.进行了组织病理学和免疫组织化学分析.
使用SPSS软件进行了统计分析.

主要成果:

在瘤芽状态和病理T阶段,杜克斯阶段和美国联合癌症委员会 (AJCC) 阶段之间观察到显著的相关性.
在瘤透淋巴细胞状态和Ki-67表达状态之间发现了显著的相关性 (p < 0.05).

结论:

结直肠癌中瘤芽的预后意义已经得到充分证实.
由于研究的样本规模较小,Her2/neu和Ki-67的预后值需要在更大的队列中进一步调查.

关键词:

他的2/neu.在 Ki-67 机器人结直肠癌结直肠癌.瘤的芽是因为瘤芽.透到瘤中的淋巴细胞

更多相关视频

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Published on: May 9, 2025

相关概念视频

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...